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Abstract: The ultimate aims of treatment of the intracranial aneurysms are 
reconstruction the vessel wall and correcting the hemodynamic disturbance. A flow 
diverter (FD) is a stent placed inside lumen of the parent artery with aim to blood flow 
reduction into the aneurysms sac to the extent of almost stagnation leading to gradual 
onset of progressive thrombosis and neointimal lining of arterial wall remodeling to 
maintain blood outflow into perforators the side and branches. Flow diverter is 
considered as an effective treatment for fusiform, wide-necked, large and giant 
intracranial unruptured aneurysms. However, FD implantation may also be associated 
with growth and rupture of residual aneurysms. The most frequent complication of 
endovascular aneurysms management is thromboembolic events and less common are  
intra and postoperative hemorrhagic aneurysmal rupture. Authors report a case where a 
lack of operation of the device as illustration is presented to demonstrate the 
shortcomings of this new type of devices. 
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Introduction 
The treatment of intracranial aneurysms 
(IA) is based on principle of isolating 
aneurysm from parent vessels, occluding 
blood flow into the aneurysm and to restore 
the physiological flow. The aneurysm 
treatment can be accomplished by surgical 
clipping of aneurysm at neck allowing 
definitive and complete aneurysm isolation 
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but carries a high risk of complications such as 
cerebral edema, arterial vasospasm, and 
infarction. A large variety of new devices for 
the treatment of IA are popping up in recent 
years with the aim to improve the prognosis of 
patients , however, the understanding of local 
hemodynamics is not still incomplete. Flow 
diverter devices (FD) are device, which is 
similar to the stent, designed with aim to 
achieve normal vessel reconstruction, and 
causing blood flow diversion along the 
anatomical course and sparing out of the flow 
vector of the neck and dome of the aneurysm. 
Recent publication show successful use of flow 
in the management of intracranial aneurysm, 
but these may fail also. [1–4] Hemodynamic 
factors are considered to play the biggest factor 
in the progression and rupture of IA. Recently 
several cases of FD failure are reported. [1, 2] 
authors reports an additional case of FD device 
and hence these devices should be considered 
for experimental use. 
According to the proposed goal in the 
treatment of intracranial aneurysms, FD is 
designed in a way to ensure complete 
management of IA and preventing possible 
associated post-treatment complication [5] i.e. 
bleeding, reconstruction of the vessel wall and 
correction of the hemodynamic flow 
abnormality [1]. Flow Diverters represents a 
new generation of stents as a superior new 
alternative treatment for IA. [4, 10, 11, 12- 16]. 
Flow diverters are a stent, placed inside the 
lumen of the main artery to reduce blood flow 
to the aneurysm causing stasis and gradually 
progressive thrombosis and subsequent 
remodeling of the inner layers of the blood 
vessel wall [4, 11, 13, 15]; keeping and 
maintaining normal blood flow [1] into the 
branches of the main artery. 
The ability of a stent to accomplish these 
goals is dependent on the amount of metal on 
its surface, the rigidity of FD, and bioactivity 
of the stent material [15]. 
Additionally, the placement of the Flow 
diverters could change vessel anatomy, 
aneurysm and finally flow to brain regions [1, 
10]. 
Hemodynamic studies suggest stent with a 
porosity above 50-70 % , can cause significant 
reduction of the flow rate to the aneurysm sac 
[1, 9, 10, 12, 13, 14], leading to progressive 
formation of thrombus and this finally causing 
total occlusion [3, 4, 10, 13, 14, 16]. However, 
clinical results of Flow diverters can be varied 
[4] and also dependent on morphology of 
aneurysm, size of neck and presence of 
branching vessel originating from fundus. In 
addition to the Flow diverters, other treatment 
options of IA include coil embolization and 
surgical clipping [3]. The middle cerebral 
artery aneurysms were evaluated in the study 
of International cohort subarachnoid 
aneurysms (ISAT) observed required two 
complementary procedures including surgical 
approaches and endovascular for the complete 
occlusion of the aneurysm [6, 15]. The surgical 
aneurysm clipping of has been considered for 
the treatment of middle cerebral artery 
aneurysms after endovascular therapy as 
presence of branches growing from where the 
aneurysm arises or the same within are always 
considered as risk factors [6]. 
Bracard et al. analyzed 140 patients with 
middle cerebral artery aneurysms, 73 had 
unruptured aneurysms. All cases received as 
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embolization coil treatment without any other 
adjuvant technique [12]. Thromboembolic 
complications were noted in 8.5%, a high 
incidence of these complications was evident 
in ruptured cases 13.7% versus 3.8% 
unruptured aneurysms [6, 9]. However, most 
frequent criticisms associated with coil 
Embolization therapy are high rate of 
aneurysm recurrence after treatment, 
incomplete occlusion and the presence of 
remnants of the aneurysm [6].  
Description of Flow Diverters: 
The pipeline embolization device (PED) is 
a mesh made tube like, composed of platinum 
(25%) and rest 75% of the alloy of cobalt and 
nickels (Fig. 1) [1, 11]. It can provides a 
coverage of 30-35% of the vessel in question 
and the common diameter of pore is 0.02 to 0.5 
mm2 [1, 14]. The coverage area provided by 
the PED is about three times of intracranial 
stent [1, 11]. Once the device is positioned 
through the segment of the aneurysm is 
released, beginning to expand and rotate for 
clockwise [1]. 
Flow Diverters with a low degree of 
porosity but a high pore density can achieving 
a further reduction of flow within the 
aneurysm sac [3, 4, 5, 10, 11]. The blood flow 
into the aneurysm is influenced by the 
geometry, the surrounding vasculature, the 
size and position of the aneurysm [4, 9, and 
13]. The aneurysm diameter also plays a very 
important role in predicting a possible rupture 
of intracranial aneurysm [4, 9, and 13]. The 
theoretical advantage of this technique is based 
on reconstruction of the main vessel, 
thrombosis of aneurysm sac of any 
morphology regardless of the aneurysm neck 
diameter [6]. These are important 
considerations which play a role in making a 
proper decision during treatment and 
influencing its possible outcomes [4]. 
Bleeding complications of Flow Diverters: 
Bleeding complications with the use of 
PED device are estimated to be 1.75%, with of 
0.75% morbidity and approximately 
1%mortality [1, 8]. Among the most frequent 
complications include ipsilateral parenchymal 
hemorrhage and subarachnoid hemorrhage 
[1]. Complications usually occur between 2-
135 days after implantation of the device [1]. 
The inflow of blood in the residual 
aneurysm during post-implantation is 
considered a risk factor [1]. Furthermore, 
leukocytes contained in the process of 
thrombus formation, activity of lytic enzymes 
such as elastase with increased activity and 
presence in the thrombi of red blood cells in 
white cell; which leave an organized formation 
of these thrombi [15] which could explain the 
subsequent breaking of intracranial 
aneurysms [1]. Wan et al. reported three 
patients treated with Flow Diverters which 
showed massive stroke after device 
implantation and bleeding during the 
procedure [2]. 
Thromboembolic complications: 
Among the most frequent risks of 
endovascular treatment the hemorrhagic 
aneurysm rupture is among them, 
intraoperative and postoperative level [7]. 
Thromboembolic complications are much 
more common [7]. The frequency of 
thromboembolic complications may vary, it 
was 7% in unruptured aneurysms cases in the 
  
 
 
 
470 | Zenteno et al - Flow diverter device failure 
 
 
 
 
 
 
 
ATHENA study by and in 12.5% of cases 
showed thromboembolic complications e 
CLARITY study [7]. Morbidity and mortality 
occurred in 3.8% of cases [7]. The stents use 
leads to increase in the perioperative stroke 
risk and usually occurs within the first 48 
postoperative hours in 10% of cases [7]. The 
risk factors for thromboembolic events are size 
and length of aneurysms [7]. The increased 
frequency of thromboembolic events may also 
be associated with the development of 
subarachnoid hemorrhage [7]. The use intra 
and post-operative anticoagulants and 
antiplatelet have been proposed to reduce the 
frequency and severity of thromboembolic 
events [7, 9]. 
Use of heparin: 
Heparin is recommended during 
interventions due to intravascular use of 
multiple tools and prolonged duration of 
procedure lasting up to many hours [7] 
prolonging the rest period the patient during 
surgery. Heparin should be initiated with a 
bolus of 3000-5000 IU followed by a dose of 
20-40 IU / kg / h continuously monitored 
blood thinners to keep clotting times between 
200 and 300 seconds [7]. This is used to 
manage irrigation thromboembolic and 
hemorrhagic of Flow diverters. World and 
Interventional Neuroradiology Federation 
and Therapeutics (WFITN) bolus 
administration recommends use of 500-1000 
IU / h continuously, with monitoring of 
clotting times around the 200s [7]. It is not 
possible to determine the concentrations of 
heparin in the blood during surgery. Usually it 
carried out prior monitoring of clotting times 
in order to see the effectiveness of this drug 
before shifting the patient to surgery [7]. Doses 
of 70-80 U / kg have been proposed in 
protocols using heparin in cardiac care 
obtaining an effective anticoagulation [7]. 
After administration of boluses of 70 U / kg 
continues with an adjustment in the dose of 
18U / kg / h and the levels of clotting times [7]. 
The WFITN do not recommend the use of 
postoperative anticoagulation [7]. No clutch, 
published clinical results have not been 
convincing, finally from a biological 
perspective seems more relevant the use of 
antiplatelet agents [7]. Furthermore it should 
be noted patients usually remain long period 
for resting on the bed during recovery time 
favoring venous stasis and possible thrombotic 
event; Ray et al. Justified the use of low 
molecular weight heparins in the post-
operative prophylactic doses in [7]. 
Antiplatelets: 
Treating an aneurysm with the use of a 
foreign body within a vascular lumen, having 
of high velocity blood flow and the possibility 
of being associated with injuries in the vessel 
wall. [7] These leads to platelet aggregation 
thus justifying the use of antiplatelet agents to 
prevent and treat intra and postoperatively 
thromboembolic complications [7, 8]. 
A study in which, protocol based use of 
antiplatelet are reviewed in three stages: 
treatment is not only in the post-operative and 
post-operative Yamada et al. [7] reported 
thromboembolic complications rates of 16%, 
2.3% and 1.9% respectively [7]. They also 
report a reduction in the rate of 
angiographically visible blood clots in patients 
who received antiplatelet pre-procedure 
compared with those who did not receive [7]. 
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The commonly used antiplatelets are 
acetylsalicylic acid, clopidogrel, prasugrel, 
among others [7]. 
Schemes: 
Unruptured aneurysms: Treatment should 
be simply coil embolization or remodeling ball 
when needed [7]. The use of anticoagulants 
and antiplatelet agents increases the risk of 
bleeding during the procedure [7]. The use of 
intraoperative heparin is recommended after 
surgery infusions of heparin should be stopped 
[7]. Simple antiplatelet therapy: 75 mg of 
aspirin only for long-necked aneurysms in 
accordance with the recommendations of the 
WFITN [7]. Should be given a loading dose of 
Clopidogrel 600 mg two hours before surgery 
and inject 250 mg of aspirin immediately after 
the other possibility is to inject antagonists of 
the glycoprotein IIb / IIIa after the aneurysm 
has assured [7] . 
Coil embolization and stent placement: 
The patient should be prepared with 75 mg / 
day of aspirin and 75 mg / day Clopidogrel for 
4-7 days prior to surgery [7], a loading dose of 
600 mg of Clopidogrel could be administered 
two hours before stent placement [7]. 
Management of thromboembolic 
complications: 
Intraoperative management of 
thromboembolic events demand a constant 
verification of clinical and biological 
parameters of each patient e.g. blood pressure 
and the degree of anticoagulation requirement 
[7]. Clotting times should be kept greater than 
250 seconds, if below, additional bolus 
administration of 2000 IU [7] is 
recommended. To reduce the risk of 
embolisms one flow diverter telescoping 
functioning as a bypass this provides an 
“incarceration “clot is used. [13] The device 
expands distal to proximal opening a new road 
and catching the clot that is occluding against 
the vessel wall; thus can prevent distal 
embolization [13]. When clots are accessible in 
the proximal artery thrombectomy could be 
considered as part of the approach [7]. 
Case Illustration  
A 56-years-old Female patient reported to 
the endovascular therapy service at the 
“Manuel Velasco Suarez” Neurology and 
Neurosurgery National Institute, for 
presenting headache with red flag symptoms. 
As precedents, various months earlier she was 
treated of giant carotid aneurysm with a FD 
(Pipeline®) in a hospital from USA. (Figure 1) 
During initial evaluation she had power 4/5 in 
left upper extremity, while the rest of the 
motor balance was within normal range. She 
underwent imaging study including MRI 
brain, Dynamic cranial CT angiography, 
showed which evidenced of residual 
aneurysmal flow and the presence of recent 
thrombus, associated with significant 
perilesional edema with mass effect. The 
patient is advised to undergo repeat MRI and 
cerebral magnetic resonance angiography 
after two weeks showing the findings (Figure 
2). The management was conservative. 
Review 
Subarachnoid hemorrhage is a devastating 
disease, whose treatment depends at time 
interval following ictus, needs advice of 
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various specialties i.e. neurosurgery, 
neurology, intensive care, and neuroradiology 
and to various forms of treatment for 
complication are medical or endovascular 
vasospasm treatment, surgical clipping / 
embolization). The concept of Flow Diverters 
for aneurysm occlusion is not new and almost 
since past ten years, it was studied in dogs to 
assess the effects of flow dynamics in 
experimental aneurysms of the carotid 
arteries. (15, 16, 17, 18). 
Filling the aneurysm and blocking or 
deflecting the inflow may promote 
thrombosis, preserving the parent vessel. 
Turowski et al [5] reported a – 69- year- old 
patient, who required the placement of a FD 
SILK-Stent, for a large par ophthalmic 
aneurysm, she developed fatal subarachnoid 
hemorrhage. Author proposes that a reduction 
in the strength of the aneurysm walls can act in 
conjunction with the residual flow as a weak 
point for mechanical rupture. This case 
demonstrates that FD is a technology to be 
tested in future, for its effectiveness, despite 
series showing good results, although such 
complications are also reported in the 
literature with unfavorable outcomes. 
 
Figure 1 - Digital subtraction angiography showing the 
micro-guide navigability through the internal carotid 
artery (ICA); also showing the stent measurements (A 
and B). Stent unfolding, through the eluting balloon 
insufflations (C and D). Total exclusion of the 
aneurysm (E). No alteration on the venous phase (F). 
Intracranial vasculature is intact (H) 
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Figure 2 - Three-dimensional reconstruction, in which 
is appreciated complete absence of the aneurysm, with 
appropriate visualization of the proximal and distal 
stent markers (A and B). – Dynamic CT angiography 
coronal and sagittal sections, where appropriate stent 
patency and showing minimal filling of the aneurysm 
(C, D, E and F) 
Conclusions 
Endovascular reconstruction using Flow 
Diverters although represent an effective 
treatment option for fusiform, long, giant, 
wide-necked aneurysms, but associated with 
5-10% of morbidity and mortality [1]. Flow 
Diverters stents assisted therapy of aneurysm 
proposes a new method of endovascular 
reconstruction of complex aneurysms, using a 
fine mesh placed outside the aneurysm sac 
reducing the flow within it subsequently cause 
thrombosis [16]. The results of the next studies 
could answer the question of how to prevent 
complications, if Flow Diverters could replace 
coil embolization or when it would certainly 
indicated the use of Flow Diverters [1]. Flow 
Dividers could reduce the risk of embolization 
associated with recanalization following 
endovascular treatment of aneurysms [20, 21, 
22]. Treatment with a single stent can alter 
hemodynamic of aneurysm creating the right 
conditions making more favorable flow 
thrombus formation [14, 15]. The most 
important goal should be complete 
elimination of the risk of post-procedural 
aneurysmal rupture, can be achieved with use 
of a single technique that does not produce 
alteration of the hemodynamic flow [20, 21, 
22]. Recent reports of multiple stent 
implantations through aneurysm neck could 
improve the effectiveness of Flow Diverters 
against reduction of blood flow to the 
aneurysm sac [20, 21, 22]. 
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